This hypothesis may partly be supported by study in a mouse model of Parkinson disease where peripheral administration of blocking antibodies against RANTES reduced the infiltration of CD4+ and CD8+ T cells into the substantia nigra and prevented the loss of dopaminergic neurons (Chandra et al. 2016). This evidence concerns the gene CCL5 and Parkinson disease.